Alios BioPharma, Inc., a biotechnology company developing proprietary therapeutics for viral diseases, announced on September 30, 2014 a definitive agreement with Johnson & Johnson whereby Alios will be acquired for…
Knobbe Martens Olson & Bear LLP, consistently ranked among the top intellectual property law firms worldwide, has been named the 2014 Top Intellectual Property Law Firm in the nation by…
Knobbe Martens Olson & Bear LLP is pleased to announce that it has successfully concluded a jury trial in Wilmington, Delaware on behalf of its longstanding client, Masimo Corp. of…
For the second consecutive year, Maria Anderson, a partner in Knobbe Martens Olson & Bear LLP’s Seattle office, has been named to Managing Intellectual Property’s list of “Top 250 Women…
On Monday, September 15, Knobbe Martens Olson & Bear LLP partner John M. Carson will be speaking at the 2014 World Intellectual Property Congress hosted by the International Association for…
FDA Publishes “Purple Book” to Catalog Biologics, Interchangeable and Biosimilar Products The US Food and Drug Administration (“FDA”) recently published its first “Lists of Licensed Biological Products with Reference Product Exclusivity and…
On Monday, September 8, Knobbe Martens Olson & Bear LLP partners Joseph Mallon, Ph.D. and Joseph Re will be speaking at the 42nd Annual Intellectual Property Owners Association (IPO)’s National…
Knobbe Martens Olson & Bear LLP is pleased to announce that 11 attorneys including Don Martens, Frederick Berretta, Joseph Cianfrani, Ned Israelsen, Joseph Re, Joseph Reisman, Art Rose, John Sganga,…
Salima Merani, Ph.D., a partner at Knobbe Martens Olson & Bear LLP, has been named to The Recorder’s list of “Women Leaders in Tech Law.” Honorees were selected by editors…
Knobbe Martens Olson & Bear LLP attorneys Cheryl Burgess, Stacey Halpern, Samantha Hsu, Lauren Keller Katzenellenbogen, Tirzah Lowe, Susan Natland, Sheila Swaroop, and Karen Vogel Weil have been named Top Women…
